Diagnostic options · UAE

Genetics tests in Dubai & UAE

Compare available Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

2,789

Listed price range

-1.00–50,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetics test prices

Showing 301–315 of 2,789 matching tests.

Genetics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-1366 Book Prenatal 60K Chromosomal Microarray (AF/CVS) + Karyotyping Test This diagnostic test evaluates fetal chromosomes for numerical and structural abnormalities using both microarray and karyotyping techniques.	Amniotic Fluid (AF) or Chorionic Villus Sampling (CVS)	7–9 working days	3,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Chromosomal copy number variations (deletions/duplications)", "Aneuploidies", "Structural rearrangements"] Parameters [{"name": "Microarray Analysis", "reference_range": "Detection of copy number variations (CNVs) at ~60 kb resolution"}, {"name": "Karyotyping Analysis", "reference_range": "Detection of aneuploidies and structural rearrangements"}] Preparation ["No specific patient preparation required prior to sample collection.", "Sample collection is performed by a qualified OB/GYN in a hospital setting."] Indications ["Advanced maternal age", "Abnormal prenatal screening results", "Family history of chromosomal abnormalities", "Abnormal ultrasound findings"] Measurement technique Confirm with laboratory Codes LOINC: 81248-4 ICD-10: O35.1 Clinical summary This diagnostic test evaluates fetal chromosomes for numerical and structural abnormalities using both microarray and karyotyping techniques.
TEST-3849 BPIFA3 Gene Genetic Test for Autism Spectrum Disorder (ASD) This test identifies pathogenic and likely pathogenic variants in the BPIFA3 gene associated with Autism Spectrum Disorder (ASD) susceptibility.	Peripheral Whole Blood	3 – 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the BPIFA3 gene", "Likely pathogenic variants in the BPIFA3 gene"] Parameters [] Preparation [] Indications ["Individuals with clinical features suggestive of ASD", "Family history of ASD"] Measurement technique Confirm with laboratory Codes LOINC: 81317-3 ICD-10: F84.0 Clinical summary This test identifies pathogenic and likely pathogenic variants in the BPIFA3 gene associated with Autism Spectrum Disorder (ASD) susceptibility.
TEST-2131 BRAF Gene Exon 15 Sequencing (Genetic Test) This test identifies activating mutations in the BRAF gene, specifically within exon 15, using Next-Generation Sequencing.	Peripheral Whole Blood (EDTA) or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BRAF gene mutations", "V600E mutation"] Parameters [] Preparation ["No fasting required", "No medication changes needed"] Indications ["Melanoma", "Colorectal cancer", "Thyroid cancer"] Measurement technique Confirm with laboratory Codes LOINC: 49590-1 ICD-10: C43.9 Clinical summary This test identifies activating mutations in the BRAF gene, specifically within exon 15, using Next-Generation Sequencing.
TEST-2647 BRAF Gene LEOPARD Syndrome Type 3 Genetic Test This test identifies germline mutations in the BRAF gene associated with LEOPARD syndrome type 3.	Whole blood (EDTA) or FTA card	14–21 working days (3–4 calendar weeks)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Germline mutations in the BRAF gene", "Point mutations", "Small indels", "Copy-number variants"] Parameters [] Preparation ["No fasting required", "Pre-test genetic counselling session mandatory"] Indications ["Suspected LEOPARD syndrome type 3", "Familial risk stratification", "Precise clinical management"] Measurement technique Confirm with laboratory Codes LOINC: 79679-8 ICD-10: Q87.89 Clinical summary This test identifies germline mutations in the BRAF gene associated with LEOPARD syndrome type 3.
TEST-2486 BRAF Gene Noonan Syndrome Type 7 Genetic Test (NGS) This test identifies pathogenic variants in the BRAF gene associated with Noonan syndrome type 7.	Blood, Extracted DNA, FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BRAF gene variants", "Pathogenic mutations"] Parameters [] Preparation ["No fasting required", "No medication changes required"] Indications ["Suspected Noonan syndrome type 7", "Family history of Noonan syndrome type 7"] Measurement technique Confirm with laboratory Codes LOINC: 79328-3 ICD-10: Q87.1, Z13.79, Z82.79 Clinical summary This test identifies pathogenic variants in the BRAF gene associated with Noonan syndrome type 7.
TEST-5411 BRAT1 Gene Neurodevelopmental Disorder with Cerebellar Atrophy and with or without Seizures Genetic Test This test identifies pathogenic variants in the BRAT1 gene, associated with a rare neurodevelopmental syndrome.	Whole Blood (3–5 mL EDTA), Extracted DNA (min 2 µg), or FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BRAT1 gene sequence", "Pathogenic variants in BRAT1 gene"] Parameters [] Preparation ["Provide a detailed referral letter from a neurologist", "Mandatory pre-test genetic counselling session"] Indications ["Unexplained global developmental delay", "Brain MRI revealing cerebellar atrophy", "Suspected BRAT1-related syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 77186-9 ICD-10: G93.89, G40.909, Q04.8 Clinical summary This test identifies pathogenic variants in the BRAT1 gene, associated with a rare neurodevelopmental syndrome.
TEST-4953 BRWD3 Gene X-Linked Intellectual Disability Type 93 Genetic Test This test identifies pathogenic variants within the BRWD3 gene associated with X-linked intellectual disability type 93.	Whole blood (peripheral)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BRWD3 gene pathogenic variants", "Missense mutations", "Nonsense mutations", "Splice-site mutations", "Small insertions/deletions"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any recent blood transfusions"] Indications ["Suspected X-linked intellectual disability type 93", "Family history of X-linked intellectual disability", "Carrier screening in female relatives"] Measurement technique Confirm with laboratory Codes LOINC: 101357-0 ICD-10: F78.9 Clinical summary This test identifies pathogenic variants within the BRWD3 gene associated with X-linked intellectual disability type 93.
TEST-4387 BSCL2 (Seipin) Gene Progressive Encephalopathy with or without Lipodystrophy Genetic Test This genetic test evaluates the BSCL2 gene for mutations associated with progressive encephalopathy and congenital generalised lipodystrophy type 2.	Peripheral Whole Blood	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single nucleotide variants in BSCL2 gene", "Small insertions or deletions in BSCL2 gene", "Copy number variations (CNVs) in BSCL2 gene"] Parameters [] Preparation ["No fasting required", "Mandatory pre-test genetic counseling session required"] Indications ["Suspected diagnosis of progressive encephalopathy", "Suspected diagnosis of congenital generalised lipodystrophy type 2 (CGL2)", "Family history of BSCL2-related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 94800-0 ICD-10: G31.89, E88.1 Clinical summary This genetic test evaluates the BSCL2 gene for mutations associated with progressive encephalopathy and congenital generalised lipodystrophy type 2.
TEST-5470 BSCL2 Gene Test This test detects pathogenic variants in the BSCL2 gene associated with Distal Hereditary Motor Neuropathy Type 5A (dHMN5A).	Whole Blood (EDTA), Extracted DNA, or Buccal Swab / FTA Card	10 to 14 Business Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the BSCL2 gene", "Coding exons and splice-site boundaries of the BSCL2 gene"] Parameters [] Preparation ["No specific fasting required", "No medication or diet restrictions"] Indications ["Suspected Distal Hereditary Motor Neuropathy Type 5A (dHMN5A)", "Differentiation from other motor neuron disorders"] Measurement technique Confirm with laboratory Codes LOINC: 77669-8 ICD-10: G12.29, G60.0 Clinical summary This test detects pathogenic variants in the BSCL2 gene associated with Distal Hereditary Motor Neuropathy Type 5A (dHMN5A).
TEST-3478 C10ORF11 Gene Oculocutaneous Albinism Type 5 (OCA5) Genetic Test This genetic test sequences the C10ORF11 gene to detect pathogenic variants associated with oculocutaneous albinism type 5 (OCA5).	Whole Blood, FTA Card, or Extracted DNA	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the C10ORF11 gene", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (Indels)", "Copy Number Variations (CNVs)"] Parameters [] Preparation ["Provide detailed clinical and family history", "Mandatory genetic counselling session", "No fasting required"] Indications ["Suspected diagnosis of Oculocutaneous Albinism Type 5 (OCA5)", "Family history of OCA5", "Genetic counseling for inherited pigmentary disorders"] Measurement technique Confirm with laboratory Codes LOINC: 94222-8 ICD-10: E70.310 Clinical summary This genetic test sequences the C10ORF11 gene to detect pathogenic variants associated with oculocutaneous albinism type 5 (OCA5).
TEST-2243 C12orf57 Gene Temtamy Syndrome Genetic Test This test analyzes the C12orf57 gene to identify mutations associated with Temtamy syndrome.	Peripheral Whole Blood (EDTA) or FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["C12orf57 gene sequence", "Mutations within the C12orf57 coding region"] Parameters [] Preparation ["No fasting required", "Continue all prescribed medications and supplements", "Written parental consent required for minors"] Indications ["Suspected Temtamy syndrome based on clinical features", "Confirmation of diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 94222-3 ICD-10: Q87.8 Clinical summary This test analyzes the C12orf57 gene to identify mutations associated with Temtamy syndrome.
TEST-6169 C12ORF65 Gene Combined Oxidative Phosphorylation Deficiency Type 7 Genetic Test This genetic test detects pathogenic variants in the C12ORF65 gene, confirming a diagnosis of Combined Oxidative Phosphorylation Deficiency Type 7.	Peripheral Whole Blood (EDTA)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the C12ORF65 gene", "Cellular energy production disruption"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any relevant medications"] Indications ["Suspected Combined Oxidative Phosphorylation Deficiency Type 7", "Confirmation of clinical diagnosis", "Metabolic management guidance", "Family planning decisions"] Measurement technique Confirm with laboratory Codes LOINC: 94828-4 ICD-10: E88.8 Clinical summary This genetic test detects pathogenic variants in the C12ORF65 gene, confirming a diagnosis of Combined Oxidative Phosphorylation Deficiency Type 7.
TEST-5682 C12ORF65 Gene SPG55 Genetic Test This test identifies pathogenic variants in the C12ORF65 gene associated with hereditary spastic paraplegia type 55 (SPG55).	Whole Blood (EDTA), Extracted DNA, or FTA Card Blood Spot	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in C12ORF65 gene coding region", "Coverage of all coding exons & splice junctions"] Parameters [] Preparation ["Mandatory pre-test genetic counselling session"] Indications ["Individuals with progressive lower-limb spasticity", "Positive family history of hereditary spastic paraplegia", "Carrier screening", "Unexplained neurological performance decline (authorized by DHA-licensed neurologist)"] Measurement technique Confirm with laboratory Codes LOINC: 81657-5 ICD-10: G11.4, Z84.0, Z13.85 Clinical summary This test identifies pathogenic variants in the C12ORF65 gene associated with hereditary spastic paraplegia type 55 (SPG55).
TEST-5762 C19orf12 Gene (SPG43) Genetic Test This test identifies pathogenic variants in the C19orf12 gene associated with autosomal recessive hereditary spastic paraplegia type 43 (SPG43).	Whole Blood (EDTA) or Dried Blood Spot (FTA Card)	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the C19orf12 gene", "Presence of mutations causing SPG43"] Parameters [] Preparation ["No fasting required", "No specific medication or diet restrictions"] Indications ["Suspected diagnosis of Hereditary Spastic Paraplegia Type 43 (SPG43)", "Family history of SPG43", "Neurological symptoms consistent with SPG43"] Measurement technique Confirm with laboratory Codes LOINC: 83402-5 ICD-10: G11.4 Clinical summary This test identifies pathogenic variants in the C19orf12 gene associated with autosomal recessive hereditary spastic paraplegia type 43 (SPG43).
TEST-5308 C19orf12 Gene Genetic Test for NBIA4/MPAN This test evaluates the C19orf12 gene for pathogenic variants associated with Neurodegeneration with Brain Iron Accumulation Type 4 (NBIA4/MPAN). It identifies specific genetic mut...	Peripheral Whole Blood (EDTA) or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the C19orf12 gene", "Copy Number Variations (CNVs) in C19orf12"] Parameters [] Preparation ["No fasting required", "Provide detailed clinical history", "Completed pedigree chart required"] Indications ["Confirming clinical diagnosis of NBIA4/MPAN", "Guiding family risk assessment", "Assessing carrier status in relatives"] Measurement technique Confirm with laboratory Codes LOINC: 55251-0 ICD-10: G23.0 Clinical summary This test evaluates the C19orf12 gene for pathogenic variants associated with Neurodegeneration with Brain Iron Accumulation Type 4 (NBIA4/MPAN). It identifies specific genetic mutations linked to this neurodegenerative disorder.

Category overview

Genetics: overview

Understanding your unique biological blueprint offers a profound sense of clarity and empowers proactive health planning for you and your family. At DNA Labs UAE, our specialized Genetics division employs state-of-the-art molecular technologies to provide deep insights into hereditary markers and cellular mutations. This comprehensive genetics testing in the UAE equips your healthcare provider with the precise data needed to tailor your medical guidance effectively. Recognized among top diagnostic labs in Dubai and the UAE, we prioritize your peace of mind through strict confidentiality protocols and exceptionally fast, accurate reporting. Take the next step in your health journey. View our genetics diagnostic services, book a private home collection, or consult our specialized team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Genetics tests in Dubai & UAE

Genetics test prices

Genetics: overview

Use the test details as a conversation starter

Related Genetics categories